MelanocortinResearch peptide

Melanotan I (Afamelanotide)

Melanotan I, marketed as afamelanotide, is a synthetic 13-amino acid analog of alpha-MSH with selectivity for MC1R. It has been clinically studied and approved in some regions for erythropoietic protoporphyria.

Also known as: Afamelanotide, NDP-MSH, Scenesse, MT-I

Technical information

Molecular weight

1646.85 g/mol

Half-life

~30 minutes (subcutaneous); extended via implant

Sequence

Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2

Common research doses

16 mg implant or 0.5-1 mg/day (research protocols)

Research areas

MC1R agonismPhotoprotectionEPP studiesPigmentation research

For research purposes only. PepAssure provides vendor information as a verification service and does not endorse or recommend any specific use. Consult qualified research protocols and institutional review boards.